Publication | Open Access

Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts

Tumor BiologyHepatocellular Carcinoma XenograftsMedicineAntiangiogenic Metronomic TherapyPathologyTumor RelapseLiver CancerOncologyCell BiologyTumor MicroenvironmentHepatocellular CarcinomaCancer Research